60 Degrees Pharmaceuticals, Inc.
SXTP· Nasdaq
Released May 15, 2025, during market hours
10-Q filed May 15, 2025, 45 days after period end · 0001213900-25-043779
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q1 2025 | Q1 2024 | Q1 2023 | Q1 2022 |
|---|---|---|---|---|
| Revenue | $163.55K | $105.67K | $17.17K | — |
| Net Income | -$1.88M | $430.47K | -$2.60M | -$907.45K |
| EPS Diluted | -$6.25 |
60 Degrees Pharmaceuticals, Inc. · CIK 1946563 · Engraved from SEC EDGAR
| $1.83 |
| -$1.13 |
| — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.